AMPA
AMPA Receptor[edit]

The AMPA receptor is a type of ionotropic glutamate receptor that is critical for fast synaptic transmission in the central nervous system. It is named after its selective agonist, _-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA). AMPA receptors are responsible for mediating most of the fast excitatory synaptic transmission in the brain.
Structure[edit]
AMPA receptors are tetrameric complexes composed of four subunits, which are designated as GluA1, GluA2, GluA3, and GluA4. These subunits can combine in various ways to form functional receptors. Each subunit consists of an extracellular N-terminal domain, a ligand-binding domain, a transmembrane domain, and an intracellular C-terminal domain.
Function[edit]
AMPA receptors are activated by the neurotransmitter glutamate, which is the primary excitatory neurotransmitter in the brain. Upon binding of glutamate, the receptor undergoes a conformational change that opens an ion channel, allowing the flow of sodium (Na_) and potassium (K_) ions across the cell membrane. This ion flow results in the depolarization of the postsynaptic neuron, leading to the propagation of an action potential.
Role in Synaptic Plasticity[edit]
AMPA receptors play a crucial role in synaptic plasticity, which is the ability of synapses to strengthen or weaken over time. This process is essential for learning and memory. One of the key mechanisms of synaptic plasticity is long-term potentiation (LTP), which involves the insertion of additional AMPA receptors into the postsynaptic membrane, thereby increasing synaptic strength.
Regulation[edit]
The function and trafficking of AMPA receptors are tightly regulated by various mechanisms, including phosphorylation, ubiquitination, and interactions with other proteins. These regulatory processes ensure that the receptors are correctly localized and that their activity is modulated in response to synaptic activity.
Clinical Significance[edit]
Dysfunction of AMPA receptors has been implicated in several neurological disorders, including epilepsy, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). Understanding the role of AMPA receptors in these conditions is important for developing potential therapeutic strategies.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian